F0XP3 Up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus

Cancer Research

Volumn 69, Issue 6, 2009, Pages 2252-2259

  Liu, Runhua ^a   Wang, Lizhong ^a   Chen, Guoyun ^a   Katoh, Hiroto ^a   Chen, Chong ^a   Liu, Yang ^a   Zheng, Pan ^a,b  

^a Cancer Center   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 4; HISTONE H3; P21 ACTIVATED KINASE; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR FOXP3; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; HDAC4 PROTEIN, HUMAN; HISTONE; HISTONE DEACETYLASE; HISTONE DEACETYLASE-2; MESSENGER RNA; REPRESSOR PROTEIN;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER TISSUE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FEMALE; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE LOCUS; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; MOUSE; NONHUMAN; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BREAST TUMOR; CHROMATIN; DRUG ANTAGONISM; GENETICS; METABOLISM; TRANSGENIC MOUSE; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HISTONE DEACETYLASES; HISTONES; HUMANS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 65549142268     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3717     Document Type: Article

References (38)

1. el-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-25.
2. Gu Y, Turck CW, Morgan DO. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 1993;366:707-10.
3. Harper JW, Adami GR, Wei N, Keyomarsi K, EUedge Sj. The p21 Cdk~interaeting protein Cipl is a potent inhibitor of Gj cyclin-dependent kinases. Cell 1993;75: 805-16.
4. Xiong Y, Harmon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993;366:701-4.
5. Pellikainen MJ, Pekola XT, Ropponen KM, et al. p21WAFl expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis. J Clin Pathol 2003;56:214-20.
6. Pinto AE, Andre S, Laranjeira C, Soares j. Correlations of cell cycle regulators (p53, p21, pRb and mdm2) and c-erbB-2 with biological markers of proliferation and overall survival in breast cancer. Pathology (Phila) 2005; 37:45-50.
7. Tiezzi DG, Andrade JM, Ribeiro-Silva A, Zola EE, Marana HR, Tiezzi MG. HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epiru- bicin combination. BMC Cancer 2007;7:36.
8. Rowland BD, Bernards R, Peeper DS. The KEE4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 2005;7:1074-82.
9. Abukhdeir AM, Vitolo Ml, Argani P, et al. Tamoxifen- stimulated growth of breast cancer due to p2I loss. Proc Natl Acad Sci U S A 2008;105:288-93.
10. Shiohara M, el-Deiry WS, Wada M, et al. Absence of WAF1 mutations in a variety of human malignancies. Blood 1994;84:3781-4.
11. 1 arrest. Cell 1994;76:1013-23.
12. 1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci U S A 1994;91:5320-4.
13. Somasundaram K, Zhang H, Zeng YX, et aL Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAFl/CiPl. Nature 1997;389:187-90.
14. Aliouat-Denis CM, Dendouga N, Van den Wyngaert I, et al. p53-independent regulation of p21Wafl/Cipl expression and senescence by Chk2. Mol Cancer Res 2005;3:627-34.
15. Chen X, Johns DC, Geiman DE, et al. Kruppel-like factor 4 (gut-enriched Kruppel-like factor) inhibits cell proliferation by blocking GrS progression of the cell cycle, j Biol Chem 2001;276:30423-8.
16. Zhang W, Geiman DE, Shields JM, et al. The gut- enriched Kruppel-like factor (Kruppel-like factor 4} mediates the transactivating effect of p53 on the p21WAFl/Cipl promoter, j Biol Chem 2000;275:18391-8.
17. Narla G, Heath KE, Reeves HE, et al. KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 2001;294:2563-6.
18. I8. Duan Z, Zarebski A, Montoya-Durango D, Grimes HL, Horwitz M. Gfil coordinates epigenetic repression of p21Cip/WAFl by recruitment of histone lysine rnethyl- transferase G9a and histone deacetylase 1. Mol Cell Biol 2005;25:10338-51,
19. Lagger G, Doetzlhofer A, Schuettengruber B, et al. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAFl/CLPl gene.Mol Cell Biol 2003;23: 2669-79.
20. Richon VM, Sandhoff TW, Rifkind RA, Marks PA. Histone deacetylase inhibitor selectively induces p21WAFl expression and gene-associated histone acet- ylation. Proc Natl Acad Sci U S A 2000;97:10014-9.
21. Xia W, Nagase S, MontiaAG, et al. BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer. Cancer Res 2008;68:1667-74.
22. Zuo T, Wang L, Morrison C, et al. FOXP3 is an X- linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell 2007;129: 1275-86.
23. Zuo T, Liu R, Zhang H, et al. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2. J Clin Invest 2007;117:3765-73.
24. Chang X, Gao JX, Jiang Q, et al. The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis. J Exp Med 2005;202:1141-51.
25. Prouty SM, Hanson KD, Boyle AL, et al. A cell culture model system for genetic analyses of the cell cycle by targeted homologous recombination. Oncogene 1993;8: 899-907.
26. Mateyak MK, Obaya AJ, Adachi S, Sedivy JM. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ 1997;8:1039-48.
27. Dai M, Wang P, Boyd AD, et al. Evolving gene/ transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 2005;33:el 75.
28. Im H, Grass JA, Johnson KD, Boyer ME, Wu j, Bresnick EH. Measurement of protein-DNA interactions in vivo by chromatin immunoprecipitation. Methods Mol Biol 2004;284:129-46.
29. Harbison CT, Gordon DR, Lee Tl, et al. Transcriptional regulatory code of a eukaryotic genome. Nature 2004;431:99-104'
30. Pic A, Lim EL, Ross Sj, et al. The forkhead protein Fkh2 is a component of the yeast cell cycle transcription factor SFF. EMBO J 2000;19:3750-61.
31. Cardinaux JR, Chapel S, Wahli W. Complex organization of CTF/NF-I, C/EBP, and HNF3 binding sites within the promoter of the liver-specific vitellogenin gene. J Biol Chem 1994;269:32947-56.
32. Kaufmann E, Knochel W. Five years on the wings of fork head. Mech Dev 1996;57:3-20.
33. Seoane J, Le HV, Massague J. Myc suppression of the p21(Cipl) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 2002;419: 729-34.
34. Mitchell KO, El-Deiry WS. Overexpression of c-Myc inhibits p21WAFl/CFPl expression and induces S-phase entry in 12-0-tetradecanoylphorbol-13-acetate (TPA)- sensitive human cancer cells. Cell Growth Differ 1999;10: 223-30.
35. Claassen GF, Hann SR. A role for transcriptional repression of p21CFPl by c-Myc in overcoming transforming growth factor β induced cell-cycle arrest. Proc Natl Acad Sci U S A 2000;97:9498-503. '
36. Chen C, Rowell FA, Thomas RM, Hancock WW, Wells AD. Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J Biol Chem 2006; 281:36828-34.
37. Chai F, Evdokiou A Young GP, Zalewski PD. Involvement of p21(Wafl/Cipl) and its cleavage by DEVD-caspase during apoptosis of colorectal cancer cells induced by butyrate. Carcinogenesis 2000; 21:7-14.
38. Samanta A, Li R, Song X, et al. TGF-p and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3. Proc Natl Acad Sci U S A 2008; 105: 14023-7.